New genome sequencing algorithm boosts human genome completeness by 20%, improving variant detection and advancing personalized medicine.

Priya Hays, Hays Documentation Specialists, LLC, discusses biomarker discovery through artificial intelligence and ...

Objective Cardiovascular diseases (CVD) remain the leading cause of mortality globally, necessitating early risk ...

Bruker Corporation today announced new advancements to enable Functional Proteomics 2.0 workflows on the timsOmnitm mass spectrometer to enable disease researchers to move beyond canonical protein ...

Market valued at $1.68B in 2024, projected to reach $4.58B by 2033 at 13.4% CAGR, driven by chronic wound prevalence ...